Integrity Alliance’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.15M Sell
7,775
-515
-6% -$522K 0.27% 84
2025
Q4
$8.91M Buy
8,290
+4,011
+94% +$3.84M 0.33% 80
2025
Q3
$3.27M Buy
4,279
+484
+13% +$360K 0.15% 122
2025
Q2
$2.96M Sell
3,795
-6,512
-63% -$5.06M 0.16% 118
2025
Q1
$8.51M Buy
10,307
+9,234
+861% +$7.68M 0.34% 70
2024
Q4
$828K Buy
+1,073
New +$888K 0.09% 105

Other funds holding LLY

Integrity Alliance's LLY Position: Q1 2026 in Review

Integrity Alliance reduced its Eli Lilly (LLY) stake by 6.2% in Q1 2026, selling an estimated $522K and leaving 7,775 shares worth $7.15M. The position accounts for 0.27% of the portfolio, ranked #84.

Integrity Alliance first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.91M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Integrity Alliance held 7,775 shares of Eli Lilly worth $7.15M as of Q1 2026.
  • Integrity Alliance sold 515 Eli Lilly shares in Q1 2026, an estimated $522K.
  • Eli Lilly made up 0.27% of Integrity Alliance's portfolio in Q1 2026, its #84 holding.
  • Integrity Alliance first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Integrity Alliance's Eli Lilly position peaked at $8.91M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Integrity Alliance's 13F filing for Q1 2026, filed 11 May 2026.